GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES

Citation
Lf. Verdonck et al., GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES, Lancet, 347(9004), 1996, pp. 800-801
Citations number
10
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
347
Issue
9004
Year of publication
1996
Pages
800 - 801
Database
ISI
SICI code
0140-6736(1996)347:9004<800:GEI2C>2.0.ZU;2-W
Abstract
Background Allogeneic bone-marrow transplantation (BMT) is associated with the graft-versus-leukaemia effect because of the antileukaemic ac tion of donor lymphocytes. We describe a graft-versus-myeloma effect a fter BMT in multiple myeloma. Methods Two patients with recurrent mult iple myeloma after allogeneic BMT (T cells partly depleted, 10(5) T ce lls infused per kg) received leucocyte infusions obtained by leukapher esis from their original marrow donors. The patients were a 48-year-ol d woman and a 49-year-old man. Findings Both patients developed graft- versus-host disease and achieved complete remission of myeloma. Chimer ism was complete in both patients in that all peripheral blood cells w ere of donor origin. Interpretation We see our results as evidence for a graft-versus-myeloma effect. Using this form of adoptive immunother apy, we could administer 1000-3000 times more T cells than with the ea rlier BMT.